News from ACRX tonight:
PR
AcelRx, in brief, is into pain. No, not Mr Grey-type pain, but the relief of such. Their NanoTab sufentanil system is a pill that melts under the tongue and is like morphine on steroids. And the device that delivers it allows the patient to safely self-dose when needed and yet prevent overdosing and drug-theft.
They already proved last November that this drug is non-inferior to morphine and the company has a third phase 3 trial that will wrap up in the 2nd quarter this year.
I'll be listening to the conference call tomorrow morning, and expect a "sunny" day share-price-wise.
Good luck to all ACRX owners.
Best,
Trond Hildahl
** This is presented for educational and informational purposes only, and should not be construed as personalized legal, tax, investment, or financial advice. My own resources, risk tolerance, and personal situation have been taken into consideration for any trades mentioned and should not be used as a basis for someone else's trades. Stocks may lose value and this is not recommendation to buy or sell this particular issue. **
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment